{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:00:57Z","timestamp":1793973657100,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019229","name":"ViewRay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jhepr.2024.101063","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:11:51Z","timestamp":1710137511000},"page":"101063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Philipp","family":"Hoegen-Sa\u00dfmannshausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5830-3616","authenticated-orcid":false,"given":"Paula","family":"Hoffmeister-Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Ben Harrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Seidensaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weykamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Ellerbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7316-6422","authenticated-orcid":false,"given":"Daniel","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-101X","authenticated-orcid":false,"given":"Christoph","family":"Springfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-4204","authenticated-orcid":false,"given":"Michael T.","family":"Dill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-1030","authenticated-orcid":false,"given":"Thomas","family":"Longerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Hua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6056-9747","authenticated-orcid":false,"given":"Oliver","family":"J\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6325-4193","authenticated-orcid":false,"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Liermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101063_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level results from the global burden of disease study 2015","volume":"3","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101063_bib3","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00330-018-5902-4","article-title":"Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database","volume":"29","author":"Uhlig","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhepr.2024.101063_bib4","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1007\/s00261-021-03069-w","article-title":"Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation\u2014part one: curative intention","volume":"46","author":"Yacoub","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhepr.2024.101063_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","article-title":"The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis","volume":"67","author":"Sapisochin","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101063_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101063_bib10","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/cncr.34965","article-title":"Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: results of a randomized clinical trial","volume":"129","author":"Bush","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2024.101063_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2023.03.064","article-title":"Transarterial chemoembolization with drug-eluting beads versus stereotactic body radiation therapy for hepatocellular carcinoma: outcomes from a multicenter, randomized, phase 2 trial (the TRENDY Trial)","volume":"117","author":"M\u00e9ndez","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijrobp.2017.09.001","article-title":"Stereotactic body radiation therapy as an alternative to transarterial chemoembolization for hepatocellular carcinoma","volume":"100","author":"Sapir","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib14","unstructured":"S3-Leitlinie Diagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms und bili\u00e4rer Karzinome. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/032-053OL."},{"key":"10.1016\/j.jhepr.2024.101063_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-017-0851-7","article-title":"Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma","volume":"12","author":"Gkika","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/liv.13191","article-title":"Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area","volume":"37","author":"Im","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101063_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in Eastern and Western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","author":"Hsieh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.radonc.2014.11.033","article-title":"Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"114","author":"Qi","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2147\/JHC.S292516","article-title":"Carbon ion radiotherapy in the management of hepatocellular carcinoma","volume":"8","author":"Abousaida","year":"2021","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jhepr.2024.101063_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2307\/3579446","article-title":"Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy","volume":"147","author":"Kanai","year":"1997","journal-title":"Radiat Res"},{"key":"10.1016\/j.jhepr.2024.101063_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2008.02.037","article-title":"Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in\u00a0vitro and in\u00a0vivo","volume":"71","author":"Els\u00e4sser","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib22","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1088\/0031-9155\/55\/22\/008","article-title":"Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model","volume":"55","author":"Inaniwa","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jhepr.2024.101063_bib23","article-title":"RBE and related modeling in carbon-ion therapy","volume":"63","author":"Karger","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jhepr.2024.101063_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/cas.15633","article-title":"Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: long-term outcomes from a phase I trial","volume":"114","author":"Hong","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhepr.2024.101063_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-11-67","article-title":"Phase I study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial","volume":"11","author":"Combs","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2024.101063_bib26","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ijrobp.2004.01.032","article-title":"Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis","volume":"59","author":"Kato","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib27","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1002\/cncr.30816","article-title":"Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials","volume":"123","author":"Kasuya","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2024.101063_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2018.10.009","article-title":"A\u00a0feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger","volume":"132","author":"Shibuya","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000520277","article-title":"Efficacy and safety of 4 fractions of carbon-ion radiation therapy for hepatocellular carcinoma: a prospective study","volume":"11","author":"Shibuya","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhepr.2024.101063_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2012.01.038","article-title":"Mapping of RBE-weighted doses between HIMAC- and LEM-based treatment planning systems for carbon ion therapy","volume":"84","author":"Steinstr\u00e4ter","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101063_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"10.1016\/j.jhepr.2024.101063_bib33","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib34","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1088\/0031-9155\/61\/11\/4141","article-title":"Clinical evaluation of 4D PET motion compensation strategies for treatment verification in ion beam therapy","volume":"61","author":"Gianoli","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jhepr.2024.101063_bib35","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1088\/0031-9155\/53\/9\/003","article-title":"Quantification of interplay effects of scanned particle beams and moving targets","volume":"53","author":"Bert","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jhepr.2024.101063_bib36","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1088\/0031-9155\/57\/7\/1779","article-title":"Respiratory liver motion estimation and its effect on scanned proton beam therapy","volume":"57","author":"Zhang","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jhepr.2024.101063_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.radonc.2014.11.020","article-title":"Residual motion mitigation in scanned carbon ion beam therapy of liver tumors using enlarged pencil beam overlap","volume":"113","author":"Richter","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2016.03.082","article-title":"Recist 1.1 - standardisation and disease-specific adaptations: perspectives from the RECIST Working Group","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2024.101063_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach - the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000479984","article-title":"Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function","volume":"6","author":"Hiraoka","year":"2017","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhepr.2024.101063_bib41","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1111\/liv.13969","article-title":"Short-course carbon-ion radiotherapy for hepatocellular carcinoma: a multi-institutional retrospective study","volume":"38","author":"Shibuya","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101063_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local control after stereotactic body radiation therapy for liver tumors","volume":"110","author":"Ohri","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2024.101063_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.dld.2018.11.004","article-title":"Phase I\/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma","volume":"51","author":"Kim","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2024.101063_bib44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A\u00a0meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101063_bib45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/add.13799","article-title":"Alcohol dependence and risk of somatic diseases and mortality: a cohort study in 19 002 men and women attending alcohol treatment","volume":"112","author":"Holst","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jhepr.2024.101063_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2022.06.006","article-title":"Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and \u03b1\/\u03b2\u00a0= 2 Gy overestimates the RBE","volume":"173","author":"Eichkorn","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jhepr.2024.101063_bib47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.14338\/IJPT-15-00041.1","article-title":"Beam delivery method for carbon-ion radiotherapy with the heavy-ion medical accelerator in Chiba","volume":"2","author":"Noda","year":"2016","journal-title":"Int J Part Ther"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:09:50Z","timestamp":1762632590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2589555924000648"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101063","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101063"}}